Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zoreline versus Zoladex pharmacokinetic study in women with endometriosis
2015-005124-25Phase 2Completed
- Sponsor
- Novalon S.A.
- Start
- May 2016
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of goserelin in endometriosis (2 arms), sponsored by Novalon S.A. Primary endpoint: Maximum measured goserelin plasma concentration. Started May 2016; status: completed.
02
Drugs
goserelin
03
Conditions
endometriosis
Beyond the preview
Go deeper on 2015-005124-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-005124-25.